These data led us to hypothesize that, upon progression of fatty liver to NASH, TRIM21 is induced to degrade A1CF and thereby reduce KHK-C expression as a protective mechanism to suppress fructose-induced steatosis. This evidence concerns the gene TRIM21 and fatty liver disease.